Avenue Therapeutics(us:ATXI)
2.08
+7.77%
Updated on 2025-01-03
Open:1.93
Close:2.08
High:2.14
Low:1.91
Pre Close:1.93
Volume:49058.00
Turnover:98878.20
Turnover Ratio:2.13%
Shares:2.30M
MarketCap:4.79M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 17 | 116357 | 9.78% | 4 | 4 | 9 |
| 2024-03-31 | 18 | 15346 | 0.03% | 3 | 4 | 6 |
| 2023-12-31 | 19 | 4345 | 0.02% | 5 | 3 | 7 |
| 2023-09-30 | 15 | 222718 | 2.48% | 3 | 2 | 5 |
| 2023-06-30 | 14 | 727658 | 9.19% | 0 | 4 | 5 |
| 2023-03-31 | 20 | 456803 | 6.69% | 6 | 3 | 8 |
| 2022-12-31 | 18 | 448868 | 9.40% | 7 | 5 | 4 |
| 2022-09-30 | 23 | 75926 | 5.13% | 4 | 3 | 15 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Sabby Management, Llc | 8943 | 0.02% | 8943 | |
| 2024-03-31 | Two Sigma Securities, Llc | 2373 | 0.01% | 2006 | 546.59% |
| 2024-03-31 | Susquehanna International Group, Llp | 959 | 0.00% | 959 | |
| 2024-03-31 | Geode Capital Management, Llc | 695 | 0.00% | 0 | |
| 2024-03-31 | Vanguard Group Inc | 617 | 0.00% | 0 | |
| 2024-03-31 | Hrt Financial Lp | 616 | 0.00% | 279 | 82.79% |
| 2024-03-31 | State Street Corp | 408 | 0.00% | 0 | |
| 2024-03-31 | Jane Street Group, Llc | 399 | 0.00% | 399 | |
| 2024-03-31 | Millennium Management Llc | 140 | 0.00% | -241 | -63.26% |
| 2024-03-31 | Tower Research Capital Llc (Trc) | 118 | 0.00% | 27 | 29.67% |
About
Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in Bay Harbor Islands, FL.
Address:1111 Kane Concourse,Suite 301
Website:http://www.avenuetx.com
Market Movers